Opioid use disorder

J Strang, ND Volkow, L Degenhardt… - Nature reviews Disease …, 2020 - nature.com
Opioid use disorder (OUD) is a chronic relapsing disorder that, whilst initially driven by
activation of brain reward neurocircuits, increasingly engages anti-reward neurocircuits that …

New directions in the treatment of opioid withdrawal

AB Srivastava, JJ Mariani, FR Levin - The Lancet, 2020 - thelancet.com
The treatment of opioid withdrawal is an important area of clinical concern when treating
patients with chronic, non-cancer pain, patients with active opioid use disorder, and patients …

Systematic evaluation of state policy interventions targeting the US opioid epidemic, 2007-2018

B Lee, W Zhao, KC Yang, YY Ahn… - JAMA network open, 2021 - jamanetwork.com
Importance In response to the increase in opioid overdose deaths in the United States, many
states recently have implemented supply-controlling and harm-reduction policy measures …

Association of racial/ethnic segregation with treatment capacity for opioid use disorder in counties in the United States

WC Goedel, A Shapiro, M Cerdá, JW Tsai… - JAMA network …, 2020 - jamanetwork.com
Importance Treatment with methadone or buprenorphine is the current standard of care for
opioid use disorder. Given the paucity of research identifying which patients will respond …

Socioeconomic risk factors for fatal opioid overdoses in the United States: Findings from the Mortality Disparities in American Communities Study (MDAC)

SF Altekruse, CM Cosgrove, WC Altekruse… - PloS one, 2020 - journals.plos.org
Background Understanding relationships between individual-level demographic,
socioeconomic status (SES) and US opioid fatalities can inform interventions in response to …

Tackling the overdose crisis: the role of safe supply

A Ivsins, J Boyd, L Beletsky, R McNeil - International Journal of Drug Policy, 2020 - Elsevier
North America is experiencing an unprecedented overdose crisis driven by the proliferation
of fentanyl and its analogues in the illicit drug supply. In 2018 there were 67,367 drug …

Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention

ND Volkow, C Blanco - World Psychiatry, 2023 - Wiley Online Library
Substance use disorders (SUDs) are highly prevalent and exact a large toll on individuals'
health, well‐being, and social functioning. Long‐lasting changes in brain networks involved …

Modulation of 5-HT release by dynorphin mediates social deficits during opioid withdrawal

MB Pomrenze, DFC Pinto, PA Neumann, P Llorach… - Neuron, 2022 - cell.com
Social isolation during opioid withdrawal is a major contributor to the current opioid
addiction crisis. We find that sociability deficits during protracted opioid withdrawal in mice …

Patient-reported outcomes of treatment of opioid dependence with weekly and monthly subcutaneous depot vs daily sublingual buprenorphine: a randomized clinical …

N Lintzeris, AJ Dunlop, PS Haber, DI Lubman… - JAMA Network …, 2021 - jamanetwork.com
Importance Patient-reported outcomes in the treatment of opioid dependence may differ
between subcutaneously administered depot buprenorphine and daily sublingual …

Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings

N Krawczyk, AR Williams, B Saloner… - Journal of Substance …, 2021 - Elsevier
Background Maintenance treatments with medications for opioid use disorder (MOUD) are
highly effective at reducing overdose risk while patients remain in care. However, few …